Lymphotoxin-a and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1379-1389

  Hagge, Deanna A ^a,e   Saunders, Bernadette M ^b,c   Ebenezer, Gigi J ^d   Ray, Nashone A ^a   Marks, Vilma T ^a   Britton, Warwick J ^b,c   Krahenbuhl, James L ^a   Adams, Linda B ^a,f  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b CENTENARY INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Anandaban Leprosy Hospital   (Nepal)

^f LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; INDUCIBLE NITRIC OXIDE SYNTHASE; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; EVOLUTION; FLOW CYTOMETRY; FOOT PAD; GRANULOMA; GRANULOMATOSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LEPROSY; LYMPH NODE; MACROPHAGE; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; PATHOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FLOW CYTOMETRY; GRANULOMA; IMMUNOHISTOCHEMISTRY; LEPROSY; LYMPHOCYTE ACTIVATION; LYMPHOTOXIN-ALPHA; MICE; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65349093399     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080550     Document Type: Article

References (49)

1. Boros DL: The cellular immunological aspects of the granulomatous response. Edited by Boros DL. Washington DC, ASM Press, 2003, pp. 1-28
2. Bean AG, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD, Britton WJ: Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999, 162:3504-3511
3. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR: Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995, 2:561-572
4. Saunders BM, Tran S, Ruuls S, Sedgwick JD, Briscoe H, Britton WJ: Transmembrane TNF is sufficient to initiate cell migration and granu- loma formation and provide acute, but not long-term, control of My- cobacterium tuberculosis infection. J Immunol 2005, 174:4852-4859
5. Zganiacz A, Santosuosso M, Wang J, Yang T, Chen L, Anzulovic M, Alexander S, Gicquel B, Wan Y, Bramson J, Inman M, Xing Z: TNF- alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 2004, 113: 401-413
6. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS: Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med 1996, 184:1999-2006
7. Ware CF: Network communications: lymphotoxins. LIGHT, and TNF. Annu Rev Immunol 2005, 23:787-819
8. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH: Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 1996, 183:1461-1472
9. Croft M: The evolving crosstalk between co-stimulatory and co-inhibitory receptors: hVEM-BTLA. Trends Immunol 2005, 26:292-294
10. Clark K, Kulk N, Amante F, Haque A, Engwerda C: Lymphotoxin alpha and tumour necrosis factor are not required for control of parasite growth, but differentially regulate cytokine production during Plas- modium chabaudi chabaudi AS infection. Parasite Immunol 2007, 29:153-158
11. Engwerda CR, Ato M, Stager S, Alexander CE, Stanley AC, Kaye PM: Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol 2004, 165:2123-2133
12. Lund FE, Partida-Sanchez S, Lee BO, Kusser KL, Hartson L, Hogan RJ, Woodland DL, Randall TD: Lymphotoxin-alpha-deficient mice make delayed, but effective. T and B cell responses to influenza. J Immunol 2002, 169:5236-5243
13. Roach DR, Briscoe H, Saunders B, France MP, Riminton S, Britton WJ: Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med 2001, 193:239-246
14. Roach DR, Briscoe H, Saunders BM, Britton WJ: Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection. Infect Immun 2005, 73:4787-4792
15. Schluter D, Kwok LY, Lutjen S, Soltek S, Hoffmann S, Korner H, Deckert M: Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J Immunol 2003, 170:6172-6182
16. Vonk AG, Netea MG, van Krieken JH, van der Meer JW, Kullberg BJ: Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-alpha- and lymphotoxin-alpha-defi- cient mice. J Infect Dis 2002, 186:1815-1822
17. Bleharski JR, Li H, Meinken C, GraeberTG, Ochoa MT, Yamamura M, Burdick A, Sarno EN, Wagner M, Rollinghoff M, Rea TH, Colonna M, Stenger S, Bloom BR, Eisenberg D, Modlin RL: Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 2003, 301:1527-1530
18. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991, 254:277-279
19. Alcais A, Alter A, Antoni G, Orlova M, Nguyen VT, Singh M, Vander- borght PR, Katoch K, Mira MT, Vu HT, Ngyuen TH, Nguyen NB, Moraes M, Mehra N, Schurr E, Abel L: Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy. Nat Genet 2007, 39:517-522
20. Korner H, Cook M, Riminton DS, Lemckert FA, Hoek RM, Ledermann B, Kontgen F, Fazekas de St Groth B, Sedgwick JD: Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol 1997, 27:2600-2609
21. Mariathasan S, Matsumoto M, Baranyay F, Nahm MH, Kanagawa O, Chaplin DD: Absence of lymph nodes in lymphotoxin-alpha (LT alpha)-deficient mice is due to abnormal organ development, not defective lymphocyte migration. J Inflamm 1995, 45:72-78
22. Riminton DS, Korner H, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD: Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J Exp Med 1998, 187:1517-1528
23. Truman RW, Krahenbuhl JL: Viable M. leprae as a research reagent. Int J Lepr Other Mycobact Dis 2001, 69:1-12
24. Lahiri R, RandhawaB, Krahenbuhl J: Application of a viability-staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad. J Med Microbiol 2005, 54:235-242
25. Hagge DA, Marks VT, Ray NA, Dietrich MA, Kearney MT, Scollard DM, Krahenbuhl JL, Adams LB: Emergence of an effective adaptive cell mediated immune response to Mycobacterium leprae is not impaired in reactive oxygen intermediate-deficient mice. FEMS Immunol Med Microbiol 2007, 51:92-101
26. Ridley DS: A logarithmic index of bacilli in biopsies. 2. Evaluation Int J Lepr Other Mycobact Dis 1967, 35:187-193
27. Lockwood DN, Lucas SB, Desikan KV, Ebenezer G, Suneetha S, Nicholls P: The histological diagnosis of leprosy type 1 reactions: identification of key variables and an analysis of the process of histological diagnosis. J Clin Pathol 2008, 61:595-600
28. Adams LB, Job CK, Krahenbuhl JL: Role of inducible nitric oxide synthase in resistance to Mycobacterium leprae in mice. Infect Im-mun 2000, 68:5462-5465
29. Adams LB, Scollard DM, Ray NA, Cooper AM, Frank AA, Orme IM, Krahenbuhl JL: The study of Mycobacterium leprae infection in inter- feron-gamma gene-disrupted mice as a model to explore the immu- nopathologic spectrum of leprosy. J Infect Dis 2002, 185 Suppl 1:S1-S8
30. Reiner SL, Sallusto F, Lanzavecchia A: Division of labor with a workforce of one: challenges in specifying effector and memory T cell fate. Science 2007, 317:622-625
31. Dobrzanski MJ, Reome JB, Hylind JC, Rewers-Felkins KA: CD8- mediated type 1 antitumor responses selectively modulate endogenous differentiated and nondifferentiated T cell localization, activation, and function in progressive breast cancer. J Immunol 2006, 177:8191-8201
32. Feng CG, Zheng L, Jankovic D, Bafica A, Cannons JL, Watford WT, Chaussabel D, Hieny S, Caspar P, Schwartzberg PL, Lenardo MJ, Sher A: The immunity-related GTPase Irgm1 promotes the expansion of activated CD4(+) T cell populations by preventing interferon- gamma-induced cell death. Nat Immunol 2008, 9:1279-1287
33. Gallegos AM, Pamer EG, Glickman MS: Delayed protection by ESAT- 6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J Exp Med 2008, 205:2359-2368
34. Hinrichs CS, Spolski R, Paulos CM, Gattinoni L, Kerstann KW, Palmer DC, Klebanoff CA, Rosenberg SA, Leonard WJ, Restifo NP: IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood 2008, 111:5326-5333
35. Kemball CC, Harkins S, Whitton JL: Enumeration and functional evaluation of virus-specific CD4+ and CD8+ T cells in lymphoid and peripheral sites of coxsackievirus B3 infection. J Virol 2008, 82:4331-4342
36. high) phenotype by an archaeosome adjuvant independent of TLR2. J Immunol 2007, 178:2396-2406
37. Reiley WW, Calayag MD, Wittmer ST, Huntington JL, Pearl JE, Fountain JJ, Martino CA, Roberts AD, Cooper AM, Winslow GM, Woodland DL: ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci USA 2008, 105:10961-10966
38. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL: The continuing challenges of leprosy. Clin Microbiol Rev 2006, 19:338-381
39. Shepard CC: The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J Exp Med 1960, 112:445-454
40. Levy L, Ji B: The mouse foot-pad technique for cultivation of Myco- bacterium leprae. Lepr Rev 2006, 77:5-24
41. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ: Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 1993, 260:355-358
42. Algood HM, Lin PL, Flynn JL: Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 2005, 41 Suppl 3:S189-S193
43. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ: TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 2002, 168:4620-4627
44. Smith S, Liggitt D, Jeromsky E, Tan X, Skerrett SJ, Wilson CB: Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection. Infect Immun 2002, 70:2082-2089
45. Cuff CA, Sacca R, Ruddle NH: Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J Immunol 1999, 162: 5965-5972
46. Weiser S, Miu J, Ball HJ, Hunt NH: Interferon-gamma synergises with tumour necrosis factor and lymphotoxin-alpha to enhance the mRNA and protein expression of adhesion molecules in mouse brain endo- thelial cells. Cytokine 2007, 37:84-91
47. Hagge DA, Ray NA, Krahenbuhl JL, Adams LB: An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages. J Immunol 2004, 172:7771-7779
48. Sibley LD, Krahenbuhl JL: Mycobacterium leprae-burdened macro- phages are refractory to activation by gamma interferon. Infect Immun 1987, 55:446-450
49. Alter A, Alcais A, Abel L, Schurr E: Leprosy as a genetic model for susceptibility to common infectious diseases. Hum Genet 2008, 123:227-235